Dapsone as corticosteroid-sparing therapy for Sweet syndrome - 17/02/22
Doi : 10.1016/j.jaad.2021.02.067
Matthew L. Hrin, BA a, ⁎ 
, Steven R. Feldman, MD, PhD a, b, c, d, William W. Huang, MD, MPH a
, Steven R. Feldman, MD, PhD a, b, c, d, William W. Huang, MD, MPH a a Center for Dermatology Research, Department of Dermatology, Wake Forest School of Medicine, Winston-Salem, North Carolina
b Department of Pathology, Wake Forest School of Medicine, Winston-Salem, North Carolina
c Department of Social Sciences & Health Policy, Wake Forest School of Medicine, Winston-Salem, North Carolina
d Department of Dermatology, University of Southern Denmark, Odense, Denmark
∗Correspondence to: Matthew L. Hrin, BA, Department of Dermatology, Wake Forest School of Medicine, Medical Center Boulevard, Winston-Salem, NC 27157-1071Department of DermatologyWake Forest School of MedicineMedical Center BoulevardWinston-SalemNC27157-1071
| Funding sources: None. |
|
| IRB approval status: Reviewed and approved by Wake Forest University Health Sciences IRB00065953. |
|
| Reprints not available from the authors. |
© 2021
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 86 - N° 3
P. 677-679 - mars 2022 Retour au numéro
Article précédent
- Clinical and psychosocial factors affecting work productivity among patients with hidradenitis suppurativa: A cluster analytical investigation
- Abdulhadi Jfri, Ivan V. Litvinov, Elena Netchiporouk, Elizabeth O'Brien
- Using cluster analysis to identify dermatologist and internist prescribing phenotypes for acne management
- John S. Barbieri, David J. Margolis
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?